The absorbance was measured at λ550-590 nm. Cell viability was calculated as a percentage of the untreated SN-38 mw Caco-2 cells. Phase contrast light microscopy

and fluorescent microscopy The Caco-2 cells were co-incubated with bacteria for 2 and 4 h. After the co-incubation monolayers were washed and imaged by phase contrast light microscopy on a Leica DM IL inverted microscope fitted with a DFC420C digital camera using LAS software. For fluorescent microscopy after the co-incubation TPX-0005 periods all detached and adherent Caco-2 cells were harvested, washed and stained with 230 μM propidium iodide/300 μM Hoechst 33342 for 5-10 min. Three hundred Caco-2 cells were analyzed and scored under the Olympus fluorescent microscope IX51 using Cell software and the DAPI filter (λ488 nm, Hoechst 33342 and PI positive) and the TxRed filter (λ520 nm, PI positive only). Immunoblotting Following co-incubation with bacteria the epithelial cells were washed in PBS and lysed with Laemmli sample buffer. Samples were resolved on Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and transferred to nitrocellulose. The membranes were incubated first with the following primary rabbit antibodies – phospho-SAPK/JNK (Thr183/Tyr185) mAb, phospho-p42/44(Thr202/Thr204) pAb, phospho-p38 (Thr180/Tyr182) pAb obtained

from Cell Signalling Technology Inc – and then with Horse Radish Peroxidase (HRP)-conjugated selleck screening library anti-rabbit IgG antibody (Jackson ImmunoReseach Laboratories). Blots were developed using the enhanced chemiluminescence detection method. Non-saturated film exposures were digitized by flatbed scanning and quantified by densitometry. To detect total level of protein the membrane was re-probed with corresponding

primary antibody: pan-JNK, p38 or p42/44 mouse mAb (R&D Systems). Cell-Based Monodansylcadaverine (MDC) Assay Caco-2 cells were seeded 24 h prior to the addition of the chemical MAPK inhibitors. Following 2 h incubation, WT V. parahaemolyticus was added to each well for 3 h. The MDC assay was performed using the Autophagy/Cytotoxicity Dual Staining Kit (Cayman Chemical Company) according to the manufacturer’s instructions. Incubation Dapagliflozin steps were carried out in the dark. All centrifuge steps were omitted. The results obtained were analyzed using a Leica DMI3000B microscope and Leica application suite V3.3.0 software. ELISA After co-incubation of the differentiated Caco-2 monolayers with V. parahaemolyticus, or 20 ηg/ml IL-1β as a positive control, IL-8 in the growth medium was detected by ELISA using the Bender Medsystem human IL-8 ELISA Kit following the manufacturer’s instructions. This detection of IL-8 was performed 6 h and 24 h after a 2 h co-incubation period which had been stopped by three successive washes with PBS and the addition of complete growth medium containing 50 μg/ml gentamicin. RNA extraction and reverse transcription PCR RNA was extracted by the Trizol method (Invitrogen).

The percentage of differentially regulated genes was calculated by dividing number of genes up- and down-regulated in each category by the total number of up- and down-regulated genes, respectively × 100. The COG functional categories are as follows: information storage and processing (includes J, translation; A, RNA processing and modification; K, transcription; L, replication, Selleckchem SAHA recombination, and repair; B, chromatin structure and dynamics); cellular processes and

signaling (includes D, cell cycle control, cell division, chromosome partitioning; MLN4924 in vitro Y, Nuclear structure; V, defense mechanisms; T, signal transduction mechanisms; M, cell wall, membrane, or envelope biogenesis; N, cell motility;

Z, cytoskeleton; W, extracellular structures; U, intracellular trafficking, secretion, and vesicular trans- port; O, posttranslational modification, protein turnover, chaperones); metabolism (includes C, energy production and conversion; G, carbohydrate transport and metabolism; Savolitinib E, amino acid transport and metabolism; F, nucleotide transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism; P, inorganic ion transport and metabolism; Q, secondary metabolite biosynthesis, transport, and catabolism); poorly characterized (includes R, general function prediction only; S, function unknown; and -, not in COGs). The most highly up-regulated gene (11.5-fold) Avelestat (AZD9668) was LIC13291, encoding a putative ankyrin repeat protein [Additional file 1]. Ankyrin repeat-containing proteins are ubiquitous proteins that play a role in protein-protein interactions [42–44]. LIC13291 is one of 12 predicted proteins with ankyrin

repeat domains in L. interrogans [34]. However, protein interactions and partners of ankyrin repeat proteins in L. interrogans have not yet been characterized. It is possible that up-regulation of this gene may be crucial for interactions of proteins involved in several functions such as intracellular signaling, nutrient acquisition, and transcriptional regulation to promote survival of Leptospira in response to stress conditions encountered in serum. Interestingly, 11 of 55 (20%) genes that were shown to be up-regulated in our study are unique to L. interrogans and are not present in the genome of the saprophytic L biflexa [45] [Additional file 1] which is susceptible to complement killing. These up-regulated unique L. interrogans genes may encode unique leptospiral virulence factors but their role, if any, in pathogenesis has yet to be determined. The complete lists of significantly up- and down-regulated genes are shown as [Additional files 1 and 2] respectively. Differentially regulated genes of known or predicted function in each broad COG category (Tables 2 and 3) are discussed below.

Structure 2002,10(11):1581–1592.PubMedCrossRef 17. Chatterji D,

Ojha AK: Revisiting the stringent response, ppGpp and starvation signaling. Curr Opin Microbiol 2001,4(2):160–165.PubMedCrossRef 18. Magnusson LU, Farewell A, Nystrom T: ppGpp: a global regulator Apoptosis inhibitor in Escherichia coli . Trends Microbiol 2005,13(5):236–242.PubMedCrossRef 19. Jiang M, Sullivan SM, Wout PK, Maddock JR: G-protein control of the ribosome-associated stress response protein SpoT. J Bacteriol 2007,189(17):6140–6147.PubMedCrossRef 20. Wout P, Pu K, Sullivan SM, Reese V, Zhou S, Lin B, Maddock JR: The Escherichia coli GTPase CgtAE cofractionates with the 50 S ribosomal subunit and interacts with SpoT, a ppGpp synthetase/hydrolase. J Bacteriol 2004,186(16):5249–5257.PubMedCrossRef 21. Raskin DM, Judson N, Mekalanos JJ: Regulation of the stringent response is the essential function of the conserved bacterial G protein CgtA in Vibrio cholerae . Proc Natl Acad Sci USA 2007,104(11):4636–4641.PubMedCrossRef 22. Rankin S, Li Z, Isberg RR: Macrophage-induced genes of Legionella selleck chemical pneumophila : protection from reactive intermediates and solute imbalance during

intracellular growth. Infect Immun 2002,70(7):3637–3648.PubMedCrossRef 23. Scott JM, Ju J, Mitchell T, Haldenwang WG: The Bacillus subtilis GTP binding protein obg and regulators of the sigma(B) stress response transcription factor cofractionate with ribosomes. J Bacteriol 2000,182(10):2771–2777.PubMedCrossRef 24. Lin B, Thayer DA, Maddock JR: The Caulobacter crescentus CgtAC protein cosediments with the free 50 S ribosomal subunit. J Bacteriol 2004,186(2):481–489.PubMedCrossRef 25. Sikora AE, Zielke R, Datta K, Maddock JR: The Vibrio harveyi GTPase CgtAV is essential and is associated with the 50 S ribosomal subunit. J Bacteriol 2006,188(3):1205–1210.PubMedCrossRef 26. Sato A, Kobayashi G, Hayashi H, why Yoshida H, Wada A, Maeda M, Hiraga S, Takeyasu

K, Wada C: The GTP binding protein Obg homolog ObgE is involved in ribosome maturation. Genes Cells 2005,10(5):393–408.PubMedCrossRef 27. WHO: Global tuberculosis control. A short update to the 2009 report. 2009. 28. Sassetti CM, Boyd DH, Rubin EJ: Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003,48(1):77–84.PubMedCrossRef 29. Comartin DJ, Brown ED: Non-ribosomal factors in ribosome subunit assembly are emerging targets for new antibacterial drugs. Curr Opin check details Pharmacol 2006,6(5):453–458.PubMedCrossRef 30. Anurag M, Dash D: Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis . Mol Biosyst 2009,5(12):1752–1757.PubMedCrossRef 31. March PE, Inouye M: GTP-binding membrane protein of Escherichia coli with sequence homology to initiation factor 2 and elongation factors Tu and G. Proc Natl Acad Sci USA 1985,82(22):7500–7504.PubMedCrossRef 32.

Blood 2002,100(5):1628–1633.PubMedCrossRef Competing interests The authors declare that they have no competing interests.

Authors’ contributions ZXS, JML and AHW designed research; YYW, YY, ZZX, LZ, LW, LZ and YC performed research; AHW and YYW analyzed data; AHW wrote the paper, JH revised the paper. eFT-508 datasheet All authors read and approved the final manuscript.”
“Background Hepatocellular carninoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer mortality [1]. Hereditary hemochromatosis (HH) is an autosomal recessive genetic condition in which excess iron is absorbed by the intestine and deposited throughout the body [2]. If untreated, affected individuals may accumulate excess iron over the many years of their adult life, and this causes progressive tissue damage [3]. It has been reported that HH may result in many diseases, including liver disease (fibrosis, cirrhosis, and hepatocellular carcinoma). Some studies reported that liver disease was the most common cause of death of patients with HH [4, 5]. In 1996, Feder and colleagues [6] showed that homozygosity for mutation (C282Y,

G>A, rs1800562) in the HFE gene was responsible for the majority of cases of typical phenotypic HH. The frequency of the second variant (H63D, C>G, rs1799945) is also increased in HH patients, but its penetrance is low. From then on, HFE gene has been postulated as a candidate gene of HCC. Some studies [7–16] demonstrated that C282Y or H63D increased the risk of HCC,

while some [17–19] gave selleck products negative results. Some large scale cohort studies [20, 21] also showed that HFE gene mutation penetrance was low and did not increase the likelihood of death from any cause among the C282Y homozygotes compared with subjects who had no C282Y mutation. However, the estimates in these cohort studies were conservative Celecoxib in the sense that in the cohort study period, a proportion of HH patients had received phlebotomy treatment. As a result, the role of C282Y and H63D mutations in HCC occurrence still merits study. To clarify the relationship between HFE C282Y and H63D mutations and HCC, a meta-analysis was performed. Methods Study identification and selection Eligible studies were identified by searching the databases of PubMed and ISI Web of Knowledge for relevant reports published before May 2009. The search criteria “”c282y OR h63d”" and “”liver cancer OR hepatocellular carcinoma”" were used. We also searched reports and dissection databases published in the Chinese Biomedical database (CBM), China National Knowledge Infrastructure (CNKI), and Wan Fang (Chinese) database to collect articles of case-control studies or cohort studies on Akt inhibitor associations between HFE mutations and susceptibility to HCC before May 2009. The reference lists of the retrieved articles were also reviewed to identify additional articles missed by the above search.

Literature-based GO annotation More than 400 research articles were read, and 71 genes with gene knockout mutations and with accession numbers and sequences deposited in public databases such as NCBI were manually annotated using GO terms, including newly developed Plant-Associated Microbe Gene Ontology (PAMGO) terms. Gene products were annotated with GO terms relevant to their biological functions. For example, 6 genes were

annotated with GO:0000187 (“”activation of MAPK activity”"), PI3K/Akt/mTOR inhibitor 5 genes with GO:0075053 (“”formation of symbiont penetration peg for entry into host”"), 14 genes with GO:0044409 (“”entry into host”"), 8 genes with GO:0044412 (“”growth or development of symbiont within host”"), and 43 genes with GO:0009405 (“”pathogenesis”"). The evidence code SNX-5422 clinical trial IMP (inferred from Mutant Phenotype) was assigned to these annotations since gene-knockout mutants were generated

in order to determine Akt inhibitor functions of these genes. A total of 210 genes were annotated on the basis of published microarray studies [3]. Again, gene products were annotated with GO terms, including PAMGO terms, relevant to their biological functions. For example, 67 genes were annotated with GO:0044271 (“”nitrogen compound biosynthetic process”"), 27 genes with GO:0075005 (“”spore germination on or near host”"), 26 genes with GO:0075035 (“”maturation of appressorium on or near host”"), and 114 genes with GO:0075016 (“”appressorium formation on or near host”"). The evidence code IEP (Inferred from expression Pattern) was assigned to these annotations on the basis that the genes were up-regulated by at least 10-fold in EGFR inhibitor association with the particular biological process.

A further 2,433 genes were annotated on the basis of published Massively Parallel Signature Sequencing (MPSS) studies [4], including 1,041 genes annotated with GO:0043581 (“”mycelium development”"), and 1,392 genes annotated with GO:0075016 (“”appressorium formation on or near host”"). The evidence code IEP was also assigned to these annotations since the genes were up-regulated only during a certain biological process, such as mycelium formation, and the fold change was equal to or greater than 10. On the basis of whole genome T-DNA insertion mutation data [5], 120 genes were annotated with relevant GO terms and PAMGO terms. For instance, 43 genes were annotated with GO:0030437 (“”ascospore formation”"), 14 genes with GO:0009847 (“”spore germination”"), 64 genes with GO:0075016 (“”appressorium formation on or near host”"), and 106 genes with GO:0009405 (“”pathogenesis”"). An evidence code IMP (inferred from mutant phenotype) was assigned to these annotations. In total, 2,810 proteins were annotated based on experimental data from published peer-reviewed literature. Of these, 1,673 proteins were annotated with terms created by the PAMGO consortium to describe interactions between symbionts and their hosts.

Results The conserved domains of CaNik1p were essential for the susceptibility of S. cerevisiae transformants to antifungals After alignment with other HKs, in CaNik1p histidine 510 and aspartate 924 were identified as the essential residues for the HisKA and the

REC domains respectively [17] and asparagine 627 for the N-box of the ATP-binding domain. Hence, to inhibit the conserved phosphorylation reactions within CaNik1p, mutant genes were generated, in which either Asn627 from the HATPase_c domain was substituted by aspartate (N627D), His510 by glutamine (H510Q) or Asp924 by asparagine (D924N). S. cerevisiae was transformed with the plasmids carrying the mutated CaNIK1 genes, and the resultant transformants were treated with the antifungals fludioxonil, MCC950 order iprodione

and ambruticin VS3. As shown in Figure 2, the strain EPZ5676 purchase YES transformed with the empty vector was resistant to all fungicides, while the strain NIK was susceptible to the studied antifungals. The H510Q and D924N point Selleck Rabusertib mutations in the HisKA and REC domains respectively, led to complete loss of susceptibility, while the N627D substitution in the HATPase_c domain only decreased the susceptibility to the fungicides in comparison to the strain NIK. Figure 2 The conserved domains of CaNik1p were essential for the susceptibility to the fungicides. The phenylpyrrole fludioxonil, the dicarboximide iprodione and the myxobacterial secondary metabolite ambruticin VS3 were used as representative PIK3C2G antifungal compounds targeting fungal group III histidine kinases. Error bars represent the standard deviation from three independent experiments. His510 and Asp924 are the conserved phosphate-accepting residues in the HisKA and the REC domains, respectively, which are required for kinase function of hybrid HKs. They are phosphorylated by the histidine kinase activity of the protein (His510) and the subsequent phosphate-transfer to the REC domain within the same protein (Asp924). Loss of fungicide susceptibility of the respective mutants suggested that the functionality

of both the HisKA and the REC domain was essential for the antifungal activity. Probably the N627D mutation did not completely prevent ATP binding to the HATPase_c domain and as a result only a partial effect was obtained. Functional HisKA, HATPase_c and REC domains were essential for the phosphorylation of Hog1p after fludioxonil treatment Treatment with fludioxonil led to phosphorylation of the MAPK Hog1p, i.e. to the activation of the HOG pathway, in S. cerevisiae transformed with full-length and truncated forms of CaNIK1[25]. Therefore, phosphorylation of Hog1p was also analyzed after fludioxonil-treatment of S. cerevisiae transformed with CaNIK1 carrying the H510Q, N627D and D924N point mutations.

The chosen Maxwell model was the best-suited model to describe and explain the recorded impedance

data most consistently for two reasons. The first reason is, it is shown in literature [15, 17] that the Co deposition can occur via at least two reaction pathways. The second reason is that the decoupling of the seven fit parameters vs. time is best for the chosen Maxwell model in comparison to other investigated equivalent circuit models as will be discussed Epigenetics in the following. The time dependence of the deposition voltage U and of the seven fit parameters – the series resistance R s, the CB-5083 research buy transfer resistance R p, the corresponding time constant τ p – are depicted in Figure 2a, the Maxwell resistances R a and R b and the corresponding capacities C a and C b in Figure 2b. Figure 2 The time dependence of the deposition voltage and the seven fit parameters. (a)

Deposition voltage U and the series resistance R Selleck GW572016 s, transfer resistance R p, and the corresponding time constant τ p and (b) the Maxwell element with R a, C a, R b, and C b as a function of the deposition time at a constant current density of 12 mA/cm2. The Co deposition voltage U decreases exponentially with time starting from a value of about −1.25 V and reaches a constant deposition voltage of about −1 V after approximately 10.5 min. The series resistance R s increases linearly with the time starting from about 90 Ω going up to about 130 Ω with slight oscillations towards the end. The transfer resistance R p is negative over the entire deposition time. It linearly increases starting from about −25 Ω up to about −35 Ω, reaching a constant level after about 16 min. Similar to the series resistance, also R p shows oscillations towards the end but significantly more pronounced in amplitude. Unlike the R p, the associated process time constant τ p remains constant over the entire deposition time. It also shows higher oscillations towards the end. In the first three minutes, the Maxwell resistance R a decreases linearly from about 18 Ω to about 16 Ω before R a

linearly increases to 18 Ω and saturates after 16 min with pronounced oscillations during the entire time. The associated capacity C oxyclozanide a does not exhibit the change in slope after three minutes as observed for R a. It decreases constantly from about 21 μF down to about 15 μF after 15 min before it saturates like R a. The Maxwell resistance R b increases linearly from about 10 Ω up to about 25 Ω. Compared to R a, the oscillations in R b are extremely reduced. The corresponding capacity C b decreases linearly from about 100 μF down to about 50 μF after 10.5 min and decreases further down to about 25 μF with a drastically reduced slope. Similar to C a, C b only shows slight oscillations over the complete deposition time.

In situation (b) a second absence due to CMD occurs > 28 days after return to work. We define this situation as recurrent sickness absence due to CMD. As in situation a, the person-years are https://www.selleckchem.com/products/poziotinib-hm781-36b.html counted from the beginning of the first episode of sickness absence due

to CMDs until the end of the employment period. In situation (c) there is a second episode of absence due to CMDs within 28 days after return to work, which is not counted as a recurrence. In the example, the employee is employed during the entire period. In situation (d) there is an episode of sickness absence due to CMDs lasting more than 1 year. The person-years are counted until 1 year of sickness absence. Fig. 1 Calculation of recurrence selleck chemical density of sickness absence due to common mental disorders The RD of sickness absence due to CMDs in the diagnostic selleck inhibitor categories was calculated by dividing the number of employees with recurrent sickness absence due to CMDs by the person-years at risk in the diagnosis-specific subpopulations, irrespective of the duration of the episodes. For example: the RD of recurrent sickness absence due to CMDs was assessed in the subpopulation of employees with a previous episode of sickness absence due to adjustment disorders. We distinguished between recurrent sickness absence due to the same type of mental disorder (adjustment disorder in the example) and recurrent sickness absence due to other types of

mental disorders. Determinants Gender, age (<35, 35–44, 45–54 and ≥55 years), marital status (married/not married), duration of employment (0–4 years, 5–9 years, 10–14 years, 15–19 years and ≥20 years), type of employment (full-time/part-time) and company (Post/Telecommunication)

were included as determinants. In 2001, the gross monthly salary scales (1–2, 3, 4–5, 6–7, ≥8) in the Post and Telecommunication companies ranged from EUR 1,656 (scale 2), 1,813 (scale 3), 2,029 (scale 5), 2,395 (scale 7) to EUR 2,675 (scale 8). Statistical analysis The duration and time-to-onset of recurrent sickness absence due to CMDs was computed in months using Kaplan–Meier survival analysis. Kaplan–Meier survival analysis allows estimation of duration times and comparison of duration times between groups, even when employees are studied for different lengths selleck compound of time. We define a rate as the sum of persons with recurrent sickness absence due to CMDs (same or other mental disorder) per unit exposure time. Not all employees are observed for the same length of time. We model counts per unit exposure time, and in our analysis person-years are handled as exposure time. We performed a log-rate analysis with this rate as dependent variable, and initial diagnosis, age, full-time/part-time, marital status, salary scale, employment characteristics and company as explaining variables. The results are presented as rate ratios (RR) with 95% confidence intervals (CI).

In addition, our results showed that both races of C. lindemuthianum express the Clpnl2 gene, although some differences are observed in the timing and level of expression: the pathogenic race responds faster and at higher levels than the non-pathogenic race. This suggests that there are at least two levels of determination of the lifestyle of the microorganisms: one related to the evolution of the enzymes and one concerning Caspase Inhibitor VI ic50 the regulation

of the expression of the enzymes. In our model, one race of C. lindemuthianum behaves as a hemibiotrophic pathogen and, according to its inability to infect bean, the other race behaves as a saprophyte. Although this study included the analysis of pectin lyase 2 only, we have observed this behavior with other enzymes of the complex involved in the degradation of the cell wall suggesting that it may be a general phenomenon. The differences at this level can be part of the general response of the fungi to host components. However future studies comparing the enzymatic complex of degradation of more fungi species with different lifestyles are needed to confirm this hypothesis. Finally, we consider this type of information to be of great importance for the study of the biotechnological potential of these enzymes, as the efficiency of the Go6983 enzymes could depend on the complexity of the vegetal material to

be processed and the lifestyle of organism that is the source of enzymes and/or genes. Acknowledgements The authors thank the financial support provided by the FOMIX CONACYT-Gobierno del Estado de Michoacán (project 2009-05 Clave 116208

to HCC) and CONACYT (scholarship granted to ALM and UCS). We thank Gerardo Vázquez Marrufo by its comments to manuscript. References JAK inhibitor 1. Willats WG, McCartney L, Mackie W, Knox JP: Pectin: cell biology and prospects for functional analysis. Plant Mol Biol 2001, 47:9–27.PubMedCrossRef 2. Mohnen D: Pectin structure and biosynthesis. Curr Opin Plant Biol 2008, 11:266–277.PubMedCrossRef 3. de Vries RP, Visser J: Aspergillus enzymes involved in degradation of plant cell wall polysaccharides. Microbiol Mol Biol Rev 2001, 65:497–522.PubMedCrossRef 4. Herron SR, Benen JA, Scavetta RD, Visser J, Jurnak F: Structure and function of pectic enzymes: BAY 11-7082 cell line virulence factors of plant pathogens. Proc Natl Acad Sci USA 2000, 97:8762–8769.PubMedCrossRef 5. Jayani RS, Saxena S, Gupta R: Microbial pectinolytic enzymes: a review. Process Biochem 2005, 40:2931–2944.CrossRef 6. Prusky D, McEvoy JL, Leverentz B, Conway WS: Local modulation of host pH by Colletotrichum species as a mechanism to increase virulence. Mol Plant Microbe Interact 2001, 14:1105–1113.PubMedCrossRef 7. Maldonado MC, Strasser de Saad AM, Callieri D: Catabolite repression of the synthesis of inducible polygalacturonase and pectinesterase by Aspergillus niger sp. Curr Microbiol 1989, 18:303–306.CrossRef 8.

Gene 2000, 246:59–68.CrossRefPubMed PLX4032 13. Lee KH, Cho MJ, Yamaoka Y, Graham DY, Yun YJ, Woo SY, Lim CY, Ko KS, Kim BJ, Jung HC, Lee WK, Rhee KH, Kook YH: Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol 2004, 42:3518–3524.CrossRefPubMed 14. Pride DT, Blaser MJ: Concerted evolution between duplicated genetic elements in

Helicobacter pylori. J Mol Biol 2002, 316:629–642.CrossRefPubMed 15. Pride DT, Meinersmann RJ, Blaser MJ: Allelic Variation within Helicobacter pylori babA and babB. Infect Immun 2001, 69:1160–1171.CrossRefPubMed 16. Kersulyte D, Velapatino B, Dailide G, Mukhopadhyay AK, Ito Y, Cahuayme L, Parkinson AJ, Gilman RH, Berg DE: Transposable element ISHp608 of Helicobacter pylori : nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol 2002, 184:992–1002.CrossRefPubMed 17. Cao P, Lee KJ, Blaser MJ, Cover TL: Analysis of hopQ alleles in East Asian and Western strains of Helicobacter pylori. FEMS Microbiol Lett 2005, 251:37–43.CrossRefPubMed 18. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust Dibutyryl-cAMP nmr TJ: Genomic-sequence

comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999, 397:176–180.CrossRefPubMed 19. Roberts RJ, Belfort M, Bestor T, Acadesine Bhagwat AS, Bickle TA, Bitinaite J, Blumenthal RM, Degtyarev SK, Dryden DT, Dybvig K, Firman K, Gromova ES, Gumport RI, Halford

SE, Hattman S, Heitman J, Hornby DP, Janulaitis A, Jeltsch A, Josephsen J, Kiss A, Klaenhammer TR, Kobayashi I, Kong H, Kruger DH, Lacks S, Marinus MG, Miyahara M, Morgan RD, Murray NE, Nagaraja V, Piekarowicz Alanine-glyoxylate transaminase A, Pingoud A, Raleigh E, Rao DN, Reich N, Repin VE, Selker EU, Shaw PC, Stein DC, Stoddard BL, Szybalski W, Trautner TA, Van Etten JL, Vitor JM, Wilson GG, Xu SY: A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes. Nucleic Acids Res 2003, 31:1805–1812.CrossRefPubMed 20. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539–547.CrossRefPubMed 21.